Pantoprazol Biomo (Pantoprazole)

Pantoprazol Biomo is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

• Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of the oesophageal lining.
• Erosive oesophagitis: accelerates healing of erosions caused by chronic acid exposure.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumours.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding irreversibly to the pump, it blocks the final step of acid secretion, leading to a sustained increase in gastric pH and reduced acidity in the stomach.

Pantoprazol Biomo is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea: occasional and transient.
• Abdominal pain: mild discomfort.
• Flatulence: increased gas formation.
• Constipation: infrequent bowel habit changes.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing.
• Clostridioides difficile infection: persistent watery diarrhea.
• Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.
• Vitamin B12 deficiency: fatigue, neuropathy with long‑term use.
• Bone fracture risk: increased incidence with prolonged therapy.
• Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

When prescribing Pantoprazol Biomo, consider the following precautions:

• Assess renal function: dose adjustment may be required in severe impairment.
• Review concomitant medications: potential for altered absorption of drugs requiring acidic pH.
• Monitor long‑term use: evaluate need for continued therapy after 8‑12 weeks.
• Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment.
• Elderly patients: start with the lowest effective dose and monitor for falls.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazol Biomo may interact with several medicines. Clinical relevance varies, so monitoring is advised.

Major Interactions (Avoid)

• Ketoconazole or itraconazole: reduced antifungal absorption leading to therapeutic failure.
• Atazanavir: decreased antiviral exposure, risking HIV treatment failure.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR, requiring more frequent coagulation monitoring.
• Digoxin: elevated serum levels may occur, necessitating dose adjustment.
• Methotrexate: reduced renal clearance can increase toxicity, especially at high doses.
• Clopidogrel: diminished antiplatelet effect, consider alternative therapy.
• Iron supplements: decreased iron absorption, advise spacing doses by at least 2 hours.